Overall rank by patents
#1,483
of 49,997 tracked assignees
USPTO PatentsView assignee record - 280 granted patents across 59 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08F (Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds).
The verdict
According to USPTO PatentsView, Nova ranks #1,483 of 49,997 tracked US assignees by granted-patent volume, with 280 patents across 59 technology areas.
USPTO PatentsView assignee plate
Corpus R1483 · Foreign Corporation #1,483 · 280 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-DENSE · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Anritsu Company (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Cambridge Enterprise · near
61 score
FMR · near
61 score
Faurecia Clarion · near
61 score
Nova Chemicals… · this assignee
61 score
UNIST(ULSAN… · near
61 score
3D Lighting… · lowest
7 score
What this shows Nova's Innovation Score is 61.0/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, Nova Chemicals (International) S.A. received 126 grants versus 133 in 2015–2019 (-5% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2018 at 34 grants and bottomed in 2023 at 18. Lead class C08F accounts for 55.7% of the portfolio across 59 subclasses. Volume neighbours: Anritsu Company (#1,479) and Astrazeneca AB (#1,487).
From 2019–2021 to 2022–2024, Nova Chemicals (International) S.A. moved from 92 to 60 grants (0.65x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,306. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Anritsu Company
280 patents
Board OF Regents OF THE University OF Nebraska
280 patents
Danfoss A/S
280 patents
Government of the United States of America, as represented by the Secretary of Commerce
280 patents
Philip Morris USA Inc.
280 patents
Senko Advanced Components, Inc.
280 patents
THE Invention Science Fund I, LLC
280 patents
Nova Chemicals (International) S.A.
280 patents
Astrazeneca AB
279 patents
What this shows Nova holds 280 patents at rank #1,483, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,483 in granted patent volume.
Other assignees with the most granted patents in Nova's primary technology class.
Two PlainPatent-derived peer sets for Nova, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (61 here).
Nearest assignees by average claims per patent (20.3 here).
Nova's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
61 Top 3% higher than 97% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 28 | 10.0% |
| 2016 | 23 | 8.2% |
| 2017 | 22 | 7.9% |
| 2018 | 34 | 12.1% |
| 2019 | 26 | 9.3% |
| 2020 | 34 | 12.1% |
| 2021 | 32 | 11.4% |
| 2022 | 20 | 7.1% |
| 2023 | 18 | 6.4% |
| 2024 | 22 | 7.9% |
| 2025partial year | 21 | 7.5% |
Top 15 of 59 technology areas
Overall rank by patents
#1,483
of 49,997 tracked assignees
61.0 out of 100
What to do with this data
Nova Chemicals (International) S.A.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.